ロード中...
Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy
CD123 targeting molecules have been widely applied in acute myelocytic leukemia (AML) therapeutics. Although antibodies have been more widely used as targeting molecules, aptamer have unique advantages for CD123 targeting therapy. In this study, we constructed an aptamer hydrogel termed as SSFH whic...
保存先:
| 出版年: | Drug Deliv |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205012/ https://ncbi.nlm.nih.gov/pubmed/34121564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2021.1934191 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|